Cat Hyperthyroidism: Radioiodine as Gold Standard

Radioiodine therapy is the most effective and welfare-friendly treatment for feline hyperthyroidism. Understanding why it is the gold standard helps owners make informed decisions.

Key Facts

Radioiodine (I-131) selectively destroys hyperfunctioning thyroid tissue while sparing normal tissue
A single treatment achieves cure rates of 95%+ in most cats
The procedure requires 1-3 days of isolation in a licensed facility while radioactivity clears
There is no surgery, no anesthesia, and no daily medication required after treatment
Cost is higher upfront than medication but typically lower over a 3-5 year treatment horizon
Radioiodine is not suitable for cats with concurrent severe kidney disease requiring careful monitoring

Welfare Considerations

Radioiodine therapy is the most welfare-positive treatment option for most hyperthyroid cats. Daily oral medication (methimazole) requires twice-daily pilling that causes stress in many cats and carries side effects including vomiting and bone marrow suppression. Thyroidectomy requires anesthesia and surgery with parathyroid gland risk. Radioiodine avoids all of these ongoing welfare costs with a single, well-tolerated procedure. The short isolation period (3-5 days) is less stressful for cats than lifelong daily medication. Its primary limitation is access — fewer facilities offer this treatment than provide medication.

What You Can Do

Ask your vet about radioiodine availability in your region as a first-line treatment discussion
Consider the lifetime welfare cost of daily pilling when comparing radioiodine cost to medication cost
Ensure your cat has a thorough renal evaluation before any treatment — kidney disease affects treatment choice
If choosing medication, ask about transdermal ear gel formulation as a less stressful alternative to oral pilling